A thermostable presentation of the live, attenuated peste des petits ruminants vaccine in use in Africa and Asia

The research objective was to develop a thermostable vaccine against peste des petits ruminants (PPR), a morbilliviral disease of small ruminants targeted for eradication that is a major constraint on the livelihoods of the rural poor throughout much of Africa and Asia. Although existing PPR vaccine...

Full description

Bibliographic Details
Main Authors: Mariner, Jeffrey C., Gachanja, J., Tindih, H.S., Toye, Philip G.
Format: Journal Article
Language:Inglés
Published: Elsevier 2017
Subjects:
Online Access:https://hdl.handle.net/10568/81517
_version_ 1855539563635671040
author Mariner, Jeffrey C.
Gachanja, J.
Tindih, H.S.
Toye, Philip G.
author_browse Gachanja, J.
Mariner, Jeffrey C.
Tindih, H.S.
Toye, Philip G.
author_facet Mariner, Jeffrey C.
Gachanja, J.
Tindih, H.S.
Toye, Philip G.
author_sort Mariner, Jeffrey C.
collection Repository of Agricultural Research Outputs (CGSpace)
description The research objective was to develop a thermostable vaccine against peste des petits ruminants (PPR), a morbilliviral disease of small ruminants targeted for eradication that is a major constraint on the livelihoods of the rural poor throughout much of Africa and Asia. Although existing PPR vaccines provide life-long immunity, they require continuous refrigeration. This limits their utility in developing countries. Methods for the lyophilization of a related morbillivirus, rinderpest (RP), resulted in vaccine that could be used in the field for up to 30 days without refrigeration which was a major contribution to the global eradication of RP completed in 2011. The present research applied the rinderpest lyophilization method to the attenuated Nigeria 75/1 PPR vaccine strain, and measured thermostability in accelerated stability tests (AST) at 37 °C. The shelf-life of the vaccine was determined as the time a vial retained the minimum dose required as a 25-dose presentation at the specified temperature. A lactalbumin hydrolysate and sucrose (LS) stabilizer was compared to stabilizers based on trehalose. PPR vaccine produced using the Xerovac drying method was compared to vaccine produced using the rinderpest lyophilization method in AST. LS vaccine was evaluated in AST at 37, 45 and 56 °C and an Arrhenius plot was constructed for estimation of stability at temperatures not tested. Vaccines produced using LS and the rinderpest method of lyophilization were the most stable. The shelf-life of the Xerovac preparation was 22.2 days at 37 °C. The three LS vaccine batches had shelf-lives at 37 °C of 177.6, 105.0 and 148.9 days, respectively, at 37 °C. At 56 °C, the shelf-life was 13.7 days. The projected half-life at 25 °C was 1.3 years. This is sufficient thermostability for use without a cold chain for up to 30 days which will greatly facilitate the delivery of vaccination in the global eradication of PPR.
format Journal Article
id CGSpace81517
institution CGIAR Consortium
language Inglés
publishDate 2017
publishDateRange 2017
publishDateSort 2017
publisher Elsevier
publisherStr Elsevier
record_format dspace
spelling CGSpace815172023-12-08T19:36:04Z A thermostable presentation of the live, attenuated peste des petits ruminants vaccine in use in Africa and Asia Mariner, Jeffrey C. Gachanja, J. Tindih, H.S. Toye, Philip G. vaccines animal diseases disease control pest of small ruminants The research objective was to develop a thermostable vaccine against peste des petits ruminants (PPR), a morbilliviral disease of small ruminants targeted for eradication that is a major constraint on the livelihoods of the rural poor throughout much of Africa and Asia. Although existing PPR vaccines provide life-long immunity, they require continuous refrigeration. This limits their utility in developing countries. Methods for the lyophilization of a related morbillivirus, rinderpest (RP), resulted in vaccine that could be used in the field for up to 30 days without refrigeration which was a major contribution to the global eradication of RP completed in 2011. The present research applied the rinderpest lyophilization method to the attenuated Nigeria 75/1 PPR vaccine strain, and measured thermostability in accelerated stability tests (AST) at 37 °C. The shelf-life of the vaccine was determined as the time a vial retained the minimum dose required as a 25-dose presentation at the specified temperature. A lactalbumin hydrolysate and sucrose (LS) stabilizer was compared to stabilizers based on trehalose. PPR vaccine produced using the Xerovac drying method was compared to vaccine produced using the rinderpest lyophilization method in AST. LS vaccine was evaluated in AST at 37, 45 and 56 °C and an Arrhenius plot was constructed for estimation of stability at temperatures not tested. Vaccines produced using LS and the rinderpest method of lyophilization were the most stable. The shelf-life of the Xerovac preparation was 22.2 days at 37 °C. The three LS vaccine batches had shelf-lives at 37 °C of 177.6, 105.0 and 148.9 days, respectively, at 37 °C. At 56 °C, the shelf-life was 13.7 days. The projected half-life at 25 °C was 1.3 years. This is sufficient thermostability for use without a cold chain for up to 30 days which will greatly facilitate the delivery of vaccination in the global eradication of PPR. 2017-06 2017-06-12T07:24:21Z 2017-06-12T07:24:21Z Journal Article https://hdl.handle.net/10568/81517 en Open Access Elsevier Mariner, J.C., Gachanja, J., Tindih, S.H. and Toye, P. 2017. A thermostable presentation of the live, attenuated peste des petits ruminants vaccine in use in Africa and Asia. Vaccine 35(30):3773-3779.
spellingShingle vaccines
animal diseases
disease control
pest of small ruminants
Mariner, Jeffrey C.
Gachanja, J.
Tindih, H.S.
Toye, Philip G.
A thermostable presentation of the live, attenuated peste des petits ruminants vaccine in use in Africa and Asia
title A thermostable presentation of the live, attenuated peste des petits ruminants vaccine in use in Africa and Asia
title_full A thermostable presentation of the live, attenuated peste des petits ruminants vaccine in use in Africa and Asia
title_fullStr A thermostable presentation of the live, attenuated peste des petits ruminants vaccine in use in Africa and Asia
title_full_unstemmed A thermostable presentation of the live, attenuated peste des petits ruminants vaccine in use in Africa and Asia
title_short A thermostable presentation of the live, attenuated peste des petits ruminants vaccine in use in Africa and Asia
title_sort thermostable presentation of the live attenuated peste des petits ruminants vaccine in use in africa and asia
topic vaccines
animal diseases
disease control
pest of small ruminants
url https://hdl.handle.net/10568/81517
work_keys_str_mv AT marinerjeffreyc athermostablepresentationoftheliveattenuatedpestedespetitsruminantsvaccineinuseinafricaandasia
AT gachanjaj athermostablepresentationoftheliveattenuatedpestedespetitsruminantsvaccineinuseinafricaandasia
AT tindihhs athermostablepresentationoftheliveattenuatedpestedespetitsruminantsvaccineinuseinafricaandasia
AT toyephilipg athermostablepresentationoftheliveattenuatedpestedespetitsruminantsvaccineinuseinafricaandasia
AT marinerjeffreyc thermostablepresentationoftheliveattenuatedpestedespetitsruminantsvaccineinuseinafricaandasia
AT gachanjaj thermostablepresentationoftheliveattenuatedpestedespetitsruminantsvaccineinuseinafricaandasia
AT tindihhs thermostablepresentationoftheliveattenuatedpestedespetitsruminantsvaccineinuseinafricaandasia
AT toyephilipg thermostablepresentationoftheliveattenuatedpestedespetitsruminantsvaccineinuseinafricaandasia